Glenmede Trust’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-8,063
| Closed | -$11K | – | 2617 |
|
|
2016
Q2 | $11K | Hold |
8,063
| – | – | ﹤0.01% | 2080 |
|
|
2016
Q1 | $11K | Hold |
8,063
| – | – | ﹤0.01% | 2018 |
|
|
2015
Q4 | $13K | Hold |
8,063
| – | – | ﹤0.01% | 1987 |
|
|
2015
Q3 | $18K | Hold |
8,063
| – | – | ﹤0.01% | 1928 |
|
|
2015
Q2 | $22K | Hold |
8,063
| – | – | ﹤0.01% | 1876 |
|
|
2015
Q1 | $27K | Hold |
8,063
| – | – | ﹤0.01% | 1855 |
|
|
2014
Q4 | $27K | Sell |
8,063
-8,100
| -50% | -$27.1K | ﹤0.01% | 1923 |
|
|
2014
Q3 | $81K | Sell |
16,163
-15,500
| -49% | -$77.7K | ﹤0.01% | 1542 |
|
|
2014
Q2 | $437K | Sell |
31,663
-33,000
| -51% | -$455K | ﹤0.01% | 913 |
|
|
2014
Q1 | $989K | Hold |
64,663
| – | – | 0.01% | 697 |
|
|
2013
Q4 | $522K | Hold |
64,663
| – | – | 0.01% | 838 |
|
|
2013
Q3 | $644K | Hold |
64,663
| – | – | 0.01% | 762 |
|
|
2013
Q2 | $274K | Buy |
+64,663
| New | +$274K | ﹤0.01% | 987 |
|